Literature DB >> 1679996

The paradoxical effects of somatostatin on the bioactivity and production of cytotoxins derived from human peripheral blood mononuclear cells.

S Yousefi1, N Vaziri, G Carandang, W Le, R Yamamoto, G Granger, J Ocariz, T Cesario.   

Abstract

Somatostatin (SMS), a naturally occurring peptide is known to inhibit the production of certain protein molecules and to diminish the ability of peripheral blood mononuclear cells to proliferate. We tested the effects of three forms of SMS on the bioactivity of both lymphotoxin (LT) and tumour necrosis factor (TNF). We also tested the effects of these agents on production of cytotoxins by peripheral blood mononuclear cells. We found the 28 amino acid form of SMS significantly enhanced the bioactivity of both LT and TNF (10(-9) M concentration) when tested in mouse L cells. The 14 amino acid form of SMS enhanced LT (10(-9) M concentration) activity but not TNF activity. The first 14 amino acid form of SMS-28 (amino terminal) did not affect bioactivity of the cytotoxin. In contrast, the naturally occurring 14 amino acid form of SMS (10(-8) M concentration) significantly diminished production of cytotoxin by human peripheral blood mononuclear cells. Cytotoxin produced by the latter was shown to be a combination of both LT and TNF. Similarly after SMS exposure, the cytotoxin produced remained a mixture of LT and TNF in roughly similar proportions. It thus appears that certain forms of SMS can enhance the bioactivity of cytotoxins, but at the same time decrease the production of these cytotoxins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1679996      PMCID: PMC1977502          DOI: 10.1038/bjc.1991.284

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  23 in total

1.  Endogenous somatostatin-like peptides of rat basophilic leukemia cells.

Authors:  E J Goetzl; T Chernov-Rogan; M P Cooke; F Renold; D G Payan
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

2.  Calcium and the production of interferon by human peripheral blood mononuclear cells.

Authors:  T C Cesario; M McCloskey; G Carandang; S Yousefi; J Chiu; N Vaziri
Journal:  J Interferon Res       Date:  1988-12

Review 3.  Lymphotoxin.

Authors:  N L Paul; N H Ruddle
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

Review 4.  Oncological applications of somatostatin analogues.

Authors:  A V Schally
Journal:  Cancer Res       Date:  1988-12-15       Impact factor: 12.701

5.  Effect of somatostatin on the proliferation of mouse spleen lymphocytes in vitro.

Authors:  M Pawlikowski; H Stepien; J Kunert-Radek; A V Schally
Journal:  Biochem Biophys Res Commun       Date:  1985-05-31       Impact factor: 3.575

Review 6.  NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut.

Authors:  P Gorden; R J Comi; P N Maton; V L Go
Journal:  Ann Intern Med       Date:  1989-01-01       Impact factor: 25.391

7.  Studies on the differing effects of tumor necrosis factor and lymphotoxin on the growth of several human tumor lines.

Authors:  J Browning; A Ribolini
Journal:  J Immunol       Date:  1989-09-15       Impact factor: 5.422

8.  Somatostatin has an antiproliferative effect on concanavalin A-activated rat thymocytes.

Authors:  R N Mascardo; R W Barton; P Sherline
Journal:  Clin Immunol Immunopathol       Date:  1984-10

9.  Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen.

Authors:  A M Stanisz; D Befus; J Bienenstock
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

10.  Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes.

Authors:  M C Cuturi; M Murphy; M P Costa-Giomi; R Weinmann; B Perussia; G Trinchieri
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

View more
  2 in total

Review 1.  Treatment of pancreatic cancer. Promises and problems of tamoxifen, somatostatin analogs, and gemcitabine.

Authors:  L Rosenberg
Journal:  Int J Pancreatol       Date:  1997-10

2.  Effects of somatostatin and octreotide on cytokine and chemokine production by lipopolysaccharide-activated peripheral blood mononuclear cells.

Authors:  F ter Veld; B Rose; R Mussmann; S Martin; C Herder; K Kempf
Journal:  J Endocrinol Invest       Date:  2009-02       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.